Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation

Haematologica

Volumn 94, Issue 10, 2009, Pages 1346-1353

  Loos, Tamara ^a   Opdenakker, Ghislain ^a   Van Damme, Jo ^a   Proost, Paul ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Chemokine; CXCL8; Leukocytosis; Neutrophil; Peptidylarginine deiminase

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; CELL ADHESION MOLECULE; INTERLEUKIN 8; L SELECTIN;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL REACTION; CIRCULATION; CITRULLINATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; RABBIT; RECEPTOR BINDING;

ANIMALS; BLOOD CIRCULATION; CELL MIGRATION ASSAYS, LEUKOCYTE; CITRULLINE; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-8; LEUKOCYTOSIS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PROTEIN BINDING; RABBITS;

EID: 70349636703     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.006973     Document Type: Article

References (44)

1. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242
2. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145-176
3. Murphy PM. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 2002;54:227-229
4. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006;6:907-918 (Pubitemid 44851733)
5. Johnson Z, Proudfoot AE, Handel TM. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 2005;16:625-636 (Pubitemid 41509199)
6. Darbonne WC, Rice GC, Mohler MA, Apple T, Hebert CA, Valente AJ, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362-1369
7. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 2005;16:687-694 (Pubitemid 41505524)
8. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009;10:101-108
9. Mortier A, Van Damme J, Proost P. Regulation of chemokine activity by posttranslational modification. Pharmacol Ther 2008;120:197-217.
10. Hebert CA, Luscinskas FW, Kiely JM, Luis EA, Darbonne WC, Bennett GL, et al. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol 1990;145:3033-3040
11. Nakagawa H, Hatakeyama S, Ikesue A, Miyai H. Generation of interleukin- 8 by plasmin from AVLPR-interleukin- 8, the human fibroblast-derived neutrophil chemotactic factor. FEBS Lett 1991;282:412-414
12. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GROalpha and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-2681 (Pubitemid 30770359)
13. 2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 1991;266:23128-23134
14. Proost P, Loos T, Mortier A, Schutyser E, Gouwy M, Noppen S, et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med 2008;205:2085-2097
15. Loos T, Mortier A, Gouwy M, Ronsse I, Put W, Lenaerts JP, et al. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation. Blood 2008;112:2648-2656
16. Starckx S, Van den Steen PE, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization. Leuk Lymphoma 2002;43:233-241 (Pubitemid 34202100)
17. van Eeden SF, Terashima T. Interleukin 8 (IL-8) and the release of leukocytes from the bone marrow. Leuk Lymphoma 2000;37:259-271 (Pubitemid 30162537)
18. Wengner AM, Pitchford SC, Furze RC, Rankin SM. The coordinated action of G-CSF and ELR+ CXC chemokines in neutrophil mobilization during acute inflammation. Blood 2008;111:42-49
19. Van Damme J, Van Beeumen J, Opdenakker G, Billiau A. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J Exp Med 1988;167:1364-1376 (Pubitemid 18121709)
20. Laterveer L, Lindley IJ, Heemskerk DP, Camps JA, Pauwels EK, Willemze R, et al. Rapid mobilization of hematopoietic progenitor cells in Rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996;87:781-788 (Pubitemid 26030335)
21. Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol 1993;150:1000-1010
22. Wuyts A, Schutyser E, Menten P, Struyf S, D'Haese A, Bult H, et al. Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages. Biochemistry 2000;39:14549-14557
23. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72:415-425 (Pubitemid 23059411)
24. Neote K, Mak JY, Kolakowski LF Jr, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994;84:44-52. (Pubitemid 24193803)
25. Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol 2008;20:525-532
26. Berton G, Lowell CA. Integrin signalling in neutrophils and macrophages. Cell Signal 1999;11: 621-635
27. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-689 (Pubitemid 47327397)
28. Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology 2008;125:281-288
29. Opdenakker G, Fibbe WE, Van Damme J. The molecular basis of leukocytosis. Immunol Today 1998;19:182-189
30. Steele RW, Steele CR, Pilkington NS Jr, Charlton RK. Functional capacity of marginated and bone marrow reserve granulocytes. Infect Immun 1987;55:2359-2363
31. Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H, Lam C, et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997;91:385-395 (Pubitemid 27467969)
32. Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology 2005;44:40-50. (Pubitemid 40124330)
33. De Rycke L, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekerckhove B, et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum 2005;52:2323-2330 (Pubitemid 41117416)
34. Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Mechin MC, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD- 4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007;56:3541-3553
35. Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, et al. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003;48: 2489-2500 (Pubitemid 37129426)
36. Burdon PC, Martin C, Rankin SM. Migration across the sinusoidal endothelium regulates neutrophil mobilization in response to ELR + CXC chemokines. Br J Haematol 2008;142:100-108 (Pubitemid 351783141)
37. Rogowski O, Sasson Y, Kassirer M, Zeltser D, Maharshak N, Arber N, et al. Down-regulation of the CD62L antigen as a possible mechanism for neutrophilia during inflammation. Br J Haematol 1998; 101:666-669 (Pubitemid 28308515)
38. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004;22:129-156
39. Mayadas TN, Cullere X. Neutrophil β2 integrins: moderators of life or death decisions. Trends Immunol 2005;26:388-395 (Pubitemid 40835845)
40. Fukuda S, Bian H, King AG, Pelus LM. The chemokine GROβ mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 2007;110:860-869 (Pubitemid 47267422)
41. King AG, Horowitz D, Dillon SB, Levin R, Farese AM, MacVittie TJ, et al. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in Rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GROb. Blood 2001;97:1534-1542 (Pubitemid 32217211)
42. Pelus LM, Fukuda S. Peripheral blood stem cell mobilization: the CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp Hematol 2006;34:1010-1020 (Pubitemid 44080384)
43. Pelus LM. Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand. Curr Opin Hematol 2008;15:285-292
44. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003;25:1106-1118